MedPath

The Effectiveness of Rehabilitation Training Based on Brain-computer Interface Technology to Improve the Upper Limb Motor Function of Ischemic Stroke.

Not Applicable
Completed
Conditions
Hemiplegia Following Ischemic Stroke
Interventions
Device: Brain-computer interface
Other: Traditional rehabilitation
Registration Number
NCT04387474
Lead Sponsor
Beijing Tiantan Hospital
Brief Summary

To evaluate the effectiveness and safety of rehabilitation training based on brain-computer interface in improving the upper motor function, self-care ability in daily life and quality of life in patients with ischemic stroke. This study adopts centralized uniform random 1:1 grouping, subjects will be randomly assigned to the experimental group and the control group. Randomization schemes are generated by statistical professionals using SAS software.

Detailed Description

Brain computer interface(BCI) is a noninvasive nervous system intervention. As a new method, it is applied in rehabilitation by stimulating peripheral nerve, such as motor, vibration, sensory, in combination with other stimulations, such as transcranial magnetic stimulation, transcranial electrical stimulation, etc.

In traditional rehabilitation therapy, hand-holding training is completed by physical therapist. Rehabilitation robot is also used for auxiliary training. BCI therapy will stimulate patients to take part in rehabilitation training more actively and obtain better effects on the rehabilitation of stroke.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Adult subjects (18 years<male or female≤80 years )
  2. Ischemic stroke diagnosed by MRI within 1 month before randomization
  3. Unilateral upper limb dysfunction with NIHSS score 1-3 at the time of randomization
  4. Informed consent signed
Exclusion Criteria
  1. Unable to understand or cooperate because of severe aphasia or cognitive impairment (CDR >0.5) or mental illness
  2. A history of epilepsy
  3. Sensory disorders or hallucinations
  4. Internal carotid artery dissection or thrombolysis
  5. Apraxia
  6. Agnosia
  7. Other diseases that may interfere with motor function
  8. Severe cardiopulmonary disease, severe illness, and unstable vital signs
  9. Severe balance dysfunction
  10. Participating in other clinical trial
  11. During pregnancy and lactation
  12. The Numerical Rating Scale (NRS) scores of upper extremities>4.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental groupTraditional rehabilitationbrain-computer interface rehabilitation training and traditional rehabilitation training.
Experimental groupBrain-computer interfacebrain-computer interface rehabilitation training and traditional rehabilitation training.
Control groupTraditional rehabilitationtraditional rehabilitation training.
Primary Outcome Measures
NameTimeMethod
The improvement of upper limb motor function at 1 month after randomization.1 month after randomization compared with traditional rehabilitation strategy.

Tested by Fugl-Meyer Assessment (FMA) scale.

Secondary Outcome Measures
NameTimeMethod
The improvement of upper limb motor function at 3 month after randomization.3 months after randomization compared with traditional rehabilitation strategy .

Tested by Fugl-Meyer Assessment (FMA) scale.

The improvement of upper limb motor function at 1, 3 month after randomization.1, 3 months after randomization compared with traditional rehabilitation strategy.

Tested by Action Research Arm Test (ARAT), The Wolf Motor Function Test (WMFT).

The improvement in muscle tone at 1, 3 month after randomization.1, 3 months after randomization compared with traditional rehabilitation strategy.

Tested by the Modified Ashworth scale (MAS).

The improvement of patients' ability to take care of themselves in daily life1, 3 months after randomization compared with traditional rehabilitation strategy.

Tested by Instrumental Activity of Daily living (IDAL).

Trial Locations

Locations (1)

China National Clinical Research Center for Neurological Diseases

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath